AJP - Endocrinology and Metabolism, Vol 263, Issue 4 E607-E614, Copyright © 1992 by American Physiological Society

ARTICLES

Functional changes in salivary glands of autoimmune disease-prone NOD mice

Y. Hu, Y. Nakagawa, K. R. Purushotham and M. G. Humphreys-Beher
Department of Oral Biology, University of Florida Health Science Center, Gainesville 32610.

Lymphocytic infiltration of the salivary glands in autoimmune diseases results in the human condition known as xerostomia. To date, an animal model for the autoimmune development of salivary gland dysfunction has yet to be described. With the autoimmune diabetes-prone nonobese diabetic (NOD) mouse strain, salivary flow rates and total saliva protein concentration in both male and female mice showed a progressive decline in the nondiabetic and diabetic states. Submandibular gland weight decreased from control mice with the progression to onset of diabetes in both sexes, whereas the weight of the parotid gland remained unchanged. The level of saliva amylase activity, when measured relative to unit volume, decreased in nondiabetic males but increased upon onset of diabetes to control values. When expressed relative to protein concentration in saliva, amylase activity was depressed for both sets of NOD mice but was higher upon diabetes onset than in the nondiabetic animals. In females a similar pattern was observed except that amylase activity expressed relative to unit volume was not significantly depressed in either set of NOD mice. The same observations were made for glandular amylase activity. The level of epidermal growth factor (a product of the ductal cells of the submandibular gland) was reduced over 500- and 18-fold for male and female diabetic mice, respectively. Sodium dodecyl sulfate polyacrylamide gels of total saliva showed changes in mobility as well as concentration of several proteins in the NOD mice.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				T. Pearson, T. G. Markees, L. S. Wicker, D. V. Serreze, L. B. Peterson, J. P. Mordes, A. A. Rossini, and D. L. Greiner NOD Congenic Mice Genetically Protected From Autoimmune Diabetes Remain Resistant to Transplantation Tolerance Induction Diabetes, February 1, 2003; 52(2): 321 - 326. [Abstract] [Full Text] [PDF]

				O. Boulard, G. Fluteau, L. Eloy, D. Damotte, P. Bedossa, and H.-J. Garchon Genetic Analysis of Autoimmune Sialadenitis in Nonobese Diabetic Mice: A Major Susceptibility Region on Chromosome 1 J. Immunol., April 15, 2002; 168(8): 4192 - 4201. [Abstract] [Full Text] [PDF]

				S. Cha, A.B. Peck, and M.G. Humphreys-Beher PROGRESS IN UNDERSTANDING AUTOIMMUNE EXOCRINOPATHY USING THE NON-OBESE DIABETIC MOUSE: AN UPDATE Crit. Rev. Oral. Biol. Med., January 1, 2002; 13(1): 5 - 16. [Abstract] [Full Text] [PDF]

				A. Nagy, H. Nagashima, S. Cha, G. E. Oxford, T. Zelles, A. B. Peck, and M. G. Humphreys-Beher Reduced Oral Wound Healing in the NOD Mouse Model for Type 1 Autoimmune Diabetes and Its Reversal by Epidermal Growth Factor Supplementation Diabetes, September 1, 2001; 50(9): 2100 - 2104. [Abstract] [Full Text] [PDF]

				D. Zoukhri and C. L. Kublin Impaired Neurotransmitter Release from Lacrimal and Salivary Gland Nerves of a Murine Model of Sjogren's Syndrome Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 925 - 932. [Abstract] [Full Text]

				K. Tsubota, H. Fujita, K. Tadano, T. Takeuchi, T. Murakami, I. Saito, and Y. Hayashi Improvement of Lacrimal Function by Topical Application of CyA in Murine Models of Sjogren's Syndrome Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 101 - 110. [Abstract] [Full Text]

				M. Yamakawa, R. Weinstein, T. Tsuji, J. McBride, D. T. W. Wong, and G. R. Login Age-related Alterations in IL-1{beta}, TNF-{alpha}, and IL-6 Concentrations in Parotid Acinar Cells from BALB/c and Non-obese Diabetic Mice J. Histochem. Cytochem., August 1, 2000; 48(8): 1033 - 1042. [Abstract] [Full Text]

				L. J. Dawson, P. M. Smith, R. J. Moots, and E. A. Field Sjogren's syndrome--time for a new approach Rheumatology, March 1, 2000; 39(3): 234 - 237. [Full Text] [PDF]

				C. P. Robinson, J. Brayer, S. Yamachika, T. R. Esch, A. B. Peck, C. A. Stewart, E. Peen, R. Jonsson, and M. G. Humphreys-Beher Transfer of human serum IgG to nonobese diabetic Igµnull mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome PNAS, June 23, 1998; 95(13): 7538 - 7543. [Abstract] [Full Text] [PDF]

				C. P. Robinson, S. Yamachika, C. E. Alford, C. Cooper, E. L. Pichardo, N. Shah, A. B. Peck, and M. G. Humphreys-Beher Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjogren syndrome PNAS, May 27, 1997; 94(11): 5767 - 5771. [Abstract] [Full Text] [PDF]